Last 12 months
Inside the activity.
1 purchase rows · 32 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 8 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 14 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 7 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 24, 2018 Filed May 25, 2018 00:23 UTC |
SCANGOS GEORGE ADirector
|
GrantOption (right to buy) · Derivative | 31,167 | $0.00 Strike: $20.50 | $0.00 |
DisclosureSEC source: 0000939767-18-000105 · wf-form4_152720773417488.xml · derivative · entry 1 SCANGOS GEORGE A · CIK 0001202102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,167 Underlying: Common Stock · 31,167 shares Expires 2025-05-23 F1 · derivative.exercise_date: Option granted pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The option is exercisable immediately, subject to repurchase provisions, and will vest as to 1/12th of the shares subject to the option each month following the date of grant, subject to the Reporting Person's continuous service through such dates. Read SEC document |
| May 24, 2018 Filed May 25, 2018 00:21 UTC |
Freire Maria CDirector
|
GrantOption (right to buy) · Derivative | 15,874 | $0.00 Strike: $20.50 | $0.00 |
DisclosureSEC source: 0000939767-18-000104 · wf-form4_152720767419905.xml · derivative · entry 2 Freire Maria C · CIK 0001547999 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,874 Underlying: Common Stock · 15,874 shares Expires 2025-05-23 F4 · derivative.exercise_date: Option granted pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The option is exercisable immediately, subject to repurchase provisions, and will vest as to 1/12th of the shares subject to the option each month following the date of grant, subject to the Reporting Person's continuous service through such dates. Read SEC document |
| May 24, 2018 Filed May 25, 2018 00:21 UTC |
Freire Maria CDirector
|
GrantCommon Stock | 7,937 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-18-000104 · wf-form4_152720767419905.xml · nonDerivative · entry 1 Freire Maria C · CIK 0001547999 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,057 F1 · security: Represents shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Exelixis, Inc. common stock. F2 · date: The restricted stock units were granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The restricted stock units will vest as to 100% of the sharessubject to the restricted stock unit award on May 24, 2019, subject to the Reporting Person's continuous service through such date. F3 · balance_after: Includes 22,057 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| May 24, 2018 Filed May 25, 2018 00:20 UTC |
Garber Alan MDirector
|
GrantOption (right to buy) · Derivative | 31,167 | $0.00 Strike: $20.50 | $0.00 |
DisclosureSEC source: 0000939767-18-000103 · wf-form4_152720762288163.xml · derivative · entry 1 Garber Alan M · CIK 0001312907 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,167 Underlying: Common Stock · 31,167 shares Expires 2025-05-23 F1 · derivative.exercise_date: Option granted pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The option is exercisable immediately, subject to repurchase provisions, and will vest as to 1/12th of the shares subject to the option each month following the date of grant, subject to the Reporting Person's continuous service through such dates. Read SEC document |
| May 24, 2018 Filed May 25, 2018 00:19 UTC |
COHEN CHARLESDirector
|
GrantOption (right to buy) · Derivative | 31,167 | $0.00 Strike: $20.50 | $0.00 |
DisclosureSEC source: 0000939767-18-000102 · wf-form4_152720756339039.xml · derivative · entry 1 COHEN CHARLES · CIK 0001202089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,167 Underlying: Common Stock · 31,167 shares Expires 2025-05-23 F1 · derivative.exercise_date: Option granted pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The option is exercisable immediately, subject to repurchase provisions, and will vest as to 1/12th of the shares subject to the option each month following the date of grant, subject to the Reporting Person's continuous service through such dates. Read SEC document |
| May 24, 2018 Filed May 25, 2018 00:18 UTC |
FELDBAUM CARL BDirector
|
GrantOption (right to buy) · Derivative | 31,167 | $0.00 Strike: $20.50 | $0.00 |
DisclosureSEC source: 0000939767-18-000101 · wf-form4_152720746245658.xml · derivative · entry 1 FELDBAUM CARL B · CIK 0001326377 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,167 Underlying: Common Stock · 31,167 shares Expires 2025-05-23 F1 · derivative.exercise_date: Option granted pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The option is exercisable immediately, subject to repurchase provisions, and will vest as to 1/12th of the shares subject to the option each month following the date of grant, subject to the Reporting Person's continuous service through such dates. Read SEC document |
| May 24, 2018 Filed May 25, 2018 00:16 UTC |
MORRISSEY MICHAELDirector · President and CEO
|
Exercise / conversionOption (right to buy) · Derivative | 90,000 | $0.00 Strike: $5.50 | $0.00 |
DisclosureSEC source: 0000939767-18-000100 · wf-form4_152720735854904.xml · derivative · entry 5 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 270,000 Underlying: Common Stock · 90,000 shares Expires 2018-09-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option, representing the right to purchase a total of 450,000 shares of Exelixis, Inc. common stock, became fully exercisable on September 28, 2015. Read SEC document |
| May 24, 2018 Filed May 25, 2018 00:16 UTC |
MORRISSEY MICHAELDirector · President and CEO
|
SaleCommon Stock | 90,000 | $20.55 | $1,849,500.00 |
DisclosureSEC source: 0000939767-18-000100 · wf-form4_152720735854904.xml · nonDerivative · entry 2 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 5, 2018. F3 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $20.22 to $20.72. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4. Read SEC document |
| May 24, 2018 Filed May 25, 2018 00:16 UTC |
MORRISSEY MICHAELDirector · President and CEO
|
Exercise / conversionCommon Stock | 90,000 | $5.50 | $495,000.00 |
DisclosureSEC source: 0000939767-18-000100 · wf-form4_152720735854904.xml · nonDerivative · entry 1 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 215,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 125,000 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units and excludes 6,653 shares previously owned directly which were contributed to the Morrissey Family Living Trust dated July 21, 1994, as amended. Read SEC document |
| May 22, 2018 Filed May 25, 2018 00:24 UTC |
WILLSEY LANCEDirector
|
SaleCommon Stock | 50,000 | $21.40 | $1,070,000.00 |
DisclosureSEC source: 0000939767-18-000106 · wf-form4_152720783720964.xml · nonDerivative · entry 1 WILLSEY LANCE · CIK 0001202106 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 418,273 F1 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $21.26 to $21.60. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4. Read SEC document |
| May 18, 2018 Filed May 19, 2018 00:02 UTC |
Haley Patrick J.Sr. Vice President, Commercial
|
SaleCommon Stock | 3,663 | $21.61 | $79,157.43 |
DisclosureSEC source: 0000939767-18-000085 · wf-form4_152668814612702.xml · nonDerivative · entry 1 Haley Patrick J. · CIK 0001692954 · Sr. Vice President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,278 F1 · balance_after: Includes 67,602 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| May 15, 2018 Filed May 16, 2018 23:59 UTC |
SCANGOS GEORGE ADirector
|
Exercise / conversionOption (right to buy) · Derivative | 15,000 | $0.00 Strike: $11.66 | $0.00 |
DisclosureSEC source: 0000939767-18-000083 · wf-form4_152651511327180.xml · derivative · entry 5 SCANGOS GEORGE A · CIK 0001202102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2018-05-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option, representing the right to purchase a total of 15,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 19, 2011. Read SEC document |
| May 15, 2018 Filed May 16, 2018 23:59 UTC |
SCANGOS GEORGE ADirector
|
Exercise / conversionCommon Stock | 15,000 | $11.66 | $174,900.00 |
DisclosureSEC source: 0000939767-18-000083 · wf-form4_152651511327180.xml · nonDerivative · entry 1 SCANGOS GEORGE A · CIK 0001202102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,478,648 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 11, 2018 Filed May 11, 2018 23:58 UTC |
MARCHESI VINCENT TDirector
|
Exercise / conversionOption (right to buy) · Derivative | 15,000 | $0.00 Strike: $11.66 | $0.00 |
DisclosureSEC source: 0000939767-18-000081 · wf-form4_152608304741745.xml · derivative · entry 3 MARCHESI VINCENT T · CIK 0001202095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2018-05-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option, representing the right to purchase a total of 15,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 19, 2011. Read SEC document |
| May 11, 2018 Filed May 11, 2018 23:58 UTC |
MARCHESI VINCENT TDirector
|
SaleCommon Stock | 15,000 | $19.03 | $285,450.00 |
DisclosureSEC source: 0000939767-18-000081 · wf-form4_152608304741745.xml · nonDerivative · entry 2 MARCHESI VINCENT T · CIK 0001202095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,913 F2 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 6, 2018. F3 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $18.85 to $19.32. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4. Read SEC document |
| May 11, 2018 Filed May 11, 2018 23:58 UTC |
MARCHESI VINCENT TDirector
|
Exercise / conversionCommon Stock | 15,000 | $11.66 | $174,900.00 |
DisclosureSEC source: 0000939767-18-000081 · wf-form4_152608304741745.xml · nonDerivative · entry 1 MARCHESI VINCENT T · CIK 0001202095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,913 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 5,843 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| May 09, 2018 Filed May 11, 2018 00:03 UTC |
COHEN CHARLESDirector
|
Exercise / conversionOption (right to buy) · Derivative | 15,000 | $0.00 Strike: $11.66 | $0.00 |
DisclosureSEC source: 0000939767-18-000079 · wf-form4_152599694362246.xml · derivative · entry 3 COHEN CHARLES · CIK 0001202089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2018-05-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option, representing the right to purchase a total of 15,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 19, 2011. Read SEC document |
| May 09, 2018 Filed May 11, 2018 00:03 UTC |
COHEN CHARLESDirector
|
SaleCommon Stock | 15,000 | $21.42 | $321,300.00 |
DisclosureSEC source: 0000939767-18-000079 · wf-form4_152599694362246.xml · nonDerivative · entry 2 COHEN CHARLES · CIK 0001202089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 248,180 F1 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $21.41 to $21.47. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4. Read SEC document |
| May 09, 2018 Filed May 11, 2018 00:03 UTC |
COHEN CHARLESDirector
|
Exercise / conversionCommon Stock | 15,000 | $11.66 | $174,900.00 |
DisclosureSEC source: 0000939767-18-000079 · wf-form4_152599694362246.xml · nonDerivative · entry 1 COHEN CHARLES · CIK 0001202089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 263,180 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 07, 2018 Filed May 8, 2018 00:07 UTC |
PAPADOPOULOS STELIOSDirector
|
Exercise / conversionOption (right to buy) · Derivative | 15,000 | $0.00 Strike: $11.66 | $0.00 |
DisclosureSEC source: 0000939767-18-000077 · wf-form4_152573806174918.xml · derivative · entry 3 PAPADOPOULOS STELIOS · CIK 0001202098 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2018-05-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option, representing the right to purchase a total of 15,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 19, 2011. Read SEC document |
| May 07, 2018 Filed May 8, 2018 00:07 UTC |
PAPADOPOULOS STELIOSDirector
|
SaleCommon Stock | 15,000 | $22.15 | $332,250.00 |
DisclosureSEC source: 0000939767-18-000077 · wf-form4_152573806174918.xml · nonDerivative · entry 2 PAPADOPOULOS STELIOS · CIK 0001202098 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,034,314 F2 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $22.13 to $22.20. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4. Read SEC document |
| May 07, 2018 Filed May 8, 2018 00:07 UTC |
PAPADOPOULOS STELIOSDirector
|
Exercise / conversionCommon Stock | 15,000 | $11.66 | $174,900.00 |
DisclosureSEC source: 0000939767-18-000077 · wf-form4_152573806174918.xml · nonDerivative · entry 1 PAPADOPOULOS STELIOS · CIK 0001202098 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,049,314 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 5,843 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| May 07, 2018 Filed May 8, 2018 00:06 UTC |
Haley Patrick J.Sr. Vice President, Commercial
|
Exercise / conversionOption (right to buy) · Derivative | 15,000 | $0.00 Strike: $1.90 | $0.00 |
DisclosureSEC source: 0000939767-18-000075 · wf-form4_152573791791835.xml · derivative · entry 8 Haley Patrick J. · CIK 0001692954 · Sr. Vice President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 15,000 shares Expires 2022-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option, representing the right to purchase a total of 85,000 shares of Exelixis, Inc. common stock, became fully exercisable on April 28, 2016. Read SEC document |
| May 07, 2018 Filed May 8, 2018 00:06 UTC |
Haley Patrick J.Sr. Vice President, Commercial
|
SaleCommon Stock | 15,000 | $22.00 | $330,000.00 |
DisclosureSEC source: 0000939767-18-000075 · wf-form4_152573791791835.xml · nonDerivative · entry 4 Haley Patrick J. · CIK 0001692954 · Sr. Vice President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,941 F3 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $22.00 to $22.04. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4 Read SEC document |
| May 07, 2018 Filed May 8, 2018 00:06 UTC |
Haley Patrick J.Sr. Vice President, Commercial
|
Exercise / conversionCommon Stock | 15,000 | $1.90 | $28,500.00 |
DisclosureSEC source: 0000939767-18-000075 · wf-form4_152573791791835.xml · nonDerivative · entry 3 Haley Patrick J. · CIK 0001692954 · Sr. Vice President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,941 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 04, 2018 Filed May 8, 2018 00:07 UTC |
Hessekiel JeffreyEVP and General Counsel
|
SaleCommon Stock | 20,000 | $22.36 | $447,200.00 |
DisclosureSEC source: 0000939767-18-000076 · wf-form4_152573800975845.xml · nonDerivative · entry 1 Hessekiel Jeffrey · CIK 0001599803 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 319,450 F1 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $22.20 to $22.52. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4. F2 · balance_after: Includes 62,187 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| May 04, 2018 Filed May 8, 2018 00:06 UTC |
Haley Patrick J.Sr. Vice President, Commercial
|
Exercise / conversionOption (right to buy) · Derivative | 10,000 | $0.00 Strike: $1.90 | $0.00 |
DisclosureSEC source: 0000939767-18-000075 · wf-form4_152573791791835.xml · derivative · entry 7 Haley Patrick J. · CIK 0001692954 · Sr. Vice President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 10,000 shares Expires 2022-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option, representing the right to purchase a total of 85,000 shares of Exelixis, Inc. common stock, became fully exercisable on April 28, 2016. Read SEC document |
| May 04, 2018 Filed May 8, 2018 00:06 UTC |
Haley Patrick J.Sr. Vice President, Commercial
|
SaleCommon Stock | 12,549 | $22.38 | $280,846.62 |
DisclosureSEC source: 0000939767-18-000075 · wf-form4_152573791791835.xml · nonDerivative · entry 2 Haley Patrick J. · CIK 0001692954 · Sr. Vice President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,941 F2 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $22.37 to $22.43. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4 Read SEC document |
| May 04, 2018 Filed May 8, 2018 00:06 UTC |
Haley Patrick J.Sr. Vice President, Commercial
|
Exercise / conversionCommon Stock | 10,000 | $1.90 | $19,000.00 |
DisclosureSEC source: 0000939767-18-000075 · wf-form4_152573791791835.xml · nonDerivative · entry 1 Haley Patrick J. · CIK 0001692954 · Sr. Vice President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,490 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 67,602 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| May 03, 2018 Filed May 4, 2018 23:06 UTC |
Schwab GiselaPres Prod Dev & Med Aff & CMO
|
Exercise / conversionOption (right to buy) · Derivative | 22,500 | $0.00 Strike: $5.50 | $0.00 |
DisclosureSEC source: 0000939767-18-000071 · wf-form4_152547516260192.xml · derivative · entry 5 Schwab Gisela · CIK 0001213140 · Pres Prod Dev & Med Aff & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,000 Underlying: Common Stock · 22,500 shares Expires 2018-09-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option, representing the right to purchase a total of 112,500 shares of Exelixis, Inc. common stock, became fully exercisable on September 28, 2015. Read SEC document |
| May 03, 2018 Filed May 4, 2018 23:06 UTC |
Schwab GiselaPres Prod Dev & Med Aff & CMO
|
SaleCommon Stock | 14,700 | $23.47 | $345,009.00 |
DisclosureSEC source: 0000939767-18-000071 · wf-form4_152547516260192.xml · nonDerivative · entry 3 Schwab Gisela · CIK 0001213140 · Pres Prod Dev & Med Aff & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 278,288 F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 2, 2018. F4 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $22.98 to $23.75. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 4 to this Form 4. Read SEC document |
| May 03, 2018 Filed May 4, 2018 23:06 UTC |
Schwab GiselaPres Prod Dev & Med Aff & CMO
|
SaleCommon Stock | 7,800 | $22.36 | $174,408.00 |
DisclosureSEC source: 0000939767-18-000071 · wf-form4_152547516260192.xml · nonDerivative · entry 2 Schwab Gisela · CIK 0001213140 · Pres Prod Dev & Med Aff & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 292,988 F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 2, 2018. F3 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $21.95 to $22.90. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4. Read SEC document |
| May 03, 2018 Filed May 4, 2018 23:06 UTC |
Schwab GiselaPres Prod Dev & Med Aff & CMO
|
Exercise / conversionCommon Stock | 22,500 | $5.50 | $123,750.00 |
DisclosureSEC source: 0000939767-18-000071 · wf-form4_152547516260192.xml · nonDerivative · entry 1 Schwab Gisela · CIK 0001213140 · Pres Prod Dev & Med Aff & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,788 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 90,000 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units and 1,008 shares of common stock acquired on April 30, 2018, pursuant to the Exelixis, Inc. 2000 Employee Stock Purchase Plan. Read SEC document |
| April 27, 2018 Filed May 1, 2018 00:23 UTC |
Hessekiel JeffreyEVP and General Counsel
|
Exercise / conversionOption (right to buy) · Derivative | 25,000 | $0.00 Strike: $1.70 | $0.00 |
DisclosureSEC source: 0000939767-18-000062 · wf-form4_152513420417985.xml · derivative · entry 3 Hessekiel Jeffrey · CIK 0001599803 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,000 Underlying: Common Stock · 25,000 shares Expires 2021-09-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option, representing the right to purchase a total of 400,000 shares of Exelixis, Inc. common stock, became fully exercisable on April 28, 2016. Read SEC document |
| April 27, 2018 Filed May 1, 2018 00:23 UTC |
Hessekiel JeffreyEVP and General Counsel
|
Exercise / conversionCommon Stock | 25,000 | $1.70 | $42,500.00 |
DisclosureSEC source: 0000939767-18-000062 · wf-form4_152513420417985.xml · nonDerivative · entry 1 Hessekiel Jeffrey · CIK 0001599803 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 339,450 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 62,187 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units and 1,008 shares of common stock acquired on April 30, 2018, pursuant to the Exelixis, Inc. 2000 Employee Stock Purchase Plan. Read SEC document |
| April 24, 2018 Filed Apr 27, 2018 00:22 UTC |
Haley Patrick J.Sr. Vice President, Commercial
|
Exercise / conversionOption (right to buy) · Derivative | 20,000 | $0.00 Strike: $1.70 | $0.00 |
DisclosureSEC source: 0000939767-18-000057 · wf-form4_152478855918815.xml · derivative · entry 4 Haley Patrick J. · CIK 0001692954 · Sr. Vice President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,000 Underlying: Common Stock · 20,000 shares Expires 2021-09-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option, representing the right to purchase a total of 120,000 shares of Exelixis, Inc. common stock, became fully exercisable on April 28, 2016. Read SEC document |
| April 24, 2018 Filed Apr 27, 2018 00:22 UTC |
Haley Patrick J.Sr. Vice President, Commercial
|
Exercise / conversionCommon Stock | 20,000 | $1.70 | $34,000.00 |
DisclosureSEC source: 0000939767-18-000057 · wf-form4_152478855918815.xml · nonDerivative · entry 1 Haley Patrick J. · CIK 0001692954 · Sr. Vice President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,490 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 67,602 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| April 16, 2018 Filed Apr 19, 2018 00:12 UTC |
WYSZOMIERSKI JACK LDirector
|
Exercise / conversionOption (right to buy) · Derivative | 15,000 | $0.00 Strike: $11.66 | $0.00 |
DisclosureSEC source: 0000939767-18-000055 · wf-form4_152409672663943.xml · derivative · entry 5 WYSZOMIERSKI JACK L · CIK 0001023225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2018-05-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option, representing the right to purchase a total of 15,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 19, 2011. Read SEC document |
| April 16, 2018 Filed Apr 19, 2018 00:12 UTC |
WYSZOMIERSKI JACK LDirector
|
Exercise / conversionOption (right to buy) · Derivative | 15,000 | $0.00 Strike: $7.97 | $0.00 |
DisclosureSEC source: 0000939767-18-000055 · wf-form4_152409672663943.xml · derivative · entry 4 WYSZOMIERSKI JACK L · CIK 0001023225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2018-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option, representing the right to purchase a total of 15,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 2, 2008. Read SEC document |
| April 16, 2018 Filed Apr 19, 2018 00:12 UTC |
WYSZOMIERSKI JACK LDirector
|
SaleCommon Stock | 14,959 | $20.25 | $302,919.75 |
DisclosureSEC source: 0000939767-18-000055 · wf-form4_152409672663943.xml · nonDerivative · entry 3 WYSZOMIERSKI JACK L · CIK 0001023225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,844 F2 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2018. F3 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $20.04 to $20.74. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4. Read SEC document |
| April 16, 2018 Filed Apr 19, 2018 00:12 UTC |
WYSZOMIERSKI JACK LDirector
|
Exercise / conversionCommon Stock | 15,000 | $11.66 | $174,900.00 |
DisclosureSEC source: 0000939767-18-000055 · wf-form4_152409672663943.xml · nonDerivative · entry 2 WYSZOMIERSKI JACK L · CIK 0001023225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,803 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 16, 2018 Filed Apr 19, 2018 00:12 UTC |
WYSZOMIERSKI JACK LDirector
|
Exercise / conversionCommon Stock | 15,000 | $7.97 | $119,550.00 |
DisclosureSEC source: 0000939767-18-000055 · wf-form4_152409672663943.xml · nonDerivative · entry 1 WYSZOMIERSKI JACK L · CIK 0001023225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,803 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 5,843 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| April 16, 2018 Filed Apr 19, 2018 00:11 UTC |
Garber Alan MDirector
|
Exercise / conversionOption (right to buy) · Derivative | 15,000 | $0.00 Strike: $11.66 | $0.00 |
DisclosureSEC source: 0000939767-18-000054 · wf-form4_152409666066391.xml · derivative · entry 3 Garber Alan M · CIK 0001312907 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2018-05-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option, representing the right to purchase a total of 15,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 19, 2011. Read SEC document |
| April 16, 2018 Filed Apr 19, 2018 00:11 UTC |
Garber Alan MDirector
|
SaleCommon Stock | 15,000 | $20.25 | $303,750.00 |
DisclosureSEC source: 0000939767-18-000054 · wf-form4_152409666066391.xml · nonDerivative · entry 2 Garber Alan M · CIK 0001312907 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,329 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 26, 2017. F2 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $20.03 to $20.73. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4. Read SEC document |
| April 16, 2018 Filed Apr 19, 2018 00:11 UTC |
Garber Alan MDirector
|
Exercise / conversionCommon Stock | 15,000 | $11.66 | $174,900.00 |
DisclosureSEC source: 0000939767-18-000054 · wf-form4_152409666066391.xml · nonDerivative · entry 1 Garber Alan M · CIK 0001312907 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,329 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 11, 2018 Filed Apr 14, 2018 00:09 UTC |
MORRISSEY MICHAELDirector · President and CEO
|
Exercise / conversionOption (right to buy) · Derivative | 90,000 | $0.00 Strike: $5.50 | $0.00 |
DisclosureSEC source: 0000939767-18-000051 · wf-form4_152366457770640.xml · derivative · entry 5 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 360,000 Underlying: Common Stock · 90,000 shares Expires 2018-09-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.expiration_date: The option, representing the right to purchase a total of 450,000 shares of Exelixis, Inc. common stock, became fully exercisable on September 28, 2015. Read SEC document |
| April 11, 2018 Filed Apr 14, 2018 00:09 UTC |
MORRISSEY MICHAELDirector · President and CEO
|
SaleCommon Stock | 90,000 | $20.78 | $1,870,200.00 |
DisclosureSEC source: 0000939767-18-000051 · wf-form4_152366457770640.xml · nonDerivative · entry 2 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,653 F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 5, 2018. F3 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $20.53 to $21.41. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4. Read SEC document |
| April 11, 2018 Filed Apr 14, 2018 00:09 UTC |
MORRISSEY MICHAELDirector · President and CEO
|
Exercise / conversionCommon Stock | 90,000 | $5.50 | $495,000.00 |
DisclosureSEC source: 0000939767-18-000051 · wf-form4_152366457770640.xml · nonDerivative · entry 1 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 221,653 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 125,000 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| April 06, 2018 Filed Apr 6, 2018 23:48 UTC |
Schwab GiselaPres Prod Dev & Med Aff & CMO
|
Exercise / conversionOption (right to buy) · Derivative | 14,591 | $0.00 Strike: $7.18 | $0.00 |
DisclosureSEC source: 0000939767-18-000042 · wf-form4_152305847475704.xml · derivative · entry 3 Schwab Gisela · CIK 0001213140 · Pres Prod Dev & Med Aff & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,109 Underlying: Common Stock · 14,591 shares Expires 2019-12-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option, representing the right to purchase a total of 210,000 shares of Exelixis, Inc. common stock, became fully exercisable on December 9, 2013. Read SEC document |
| April 06, 2018 Filed Apr 6, 2018 23:48 UTC |
Schwab GiselaPres Prod Dev & Med Aff & CMO
|
Exercise / conversionCommon Stock | 14,591 | $7.18 | $104,763.38 |
DisclosureSEC source: 0000939767-18-000042 · wf-form4_152305847475704.xml · nonDerivative · entry 1 Schwab Gisela · CIK 0001213140 · Pres Prod Dev & Med Aff & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 277,280 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 90,000 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.